COCH
Envoy Medical, Inc.NASDAQHealthcare$0.75-5.69%ClosedMarket Cap: $15.5M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-1.17
P/S
60.85
EV/EBITDA
-0.54
DCF Value
$0.03
FCF Yield
-125.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-262.7%
Operating Margin
-9240.7%
Net Margin
-9857.3%
ROE
129.5%
ROA
-277.6%
ROIC
786.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $75.0K | $-6.6M | $-0.27 |
| FY 2025 | $241.0K | $-23.8M | $-1.23 |
| Q3 2025 | $42.0K | $-6.5M | $-0.35 |
| Q2 2025 | $78.0K | $-5.7M | $-0.32 |
Analyst Ratings
View AllAscendiant CapitalBuy
2025-05-27Ascendiant CapitalBuy
2025-04-21Trading Activity
Insider Trades
View AllPatel Mona Chetandirector
BuyTue Feb 17
Patel Mona Chetandirector
BuyTue Feb 17
Potashnick Robertofficer: Interim CFO
BuyTue Feb 17
Potashnick Robertofficer: Interim CFO
BuyTue Feb 17
Kantor Susandirector
BuyTue Feb 17
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
2.05
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.